Fludarabine Phosphate for Injection,
USP
| General Information: Fludarabine
phosphate injection is typically utilized in the treatment of B-cell chronic lymphocytic leukemia. For indication, dosing or other information, please refer to the manufacture package insert. |
| |
| Manufacturer |
Products |
Size |
NDC |
PI |
MSDS |
| Sagent |
Fludarabine |
50mg |
25201-0205-05 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Fludarabine Phosphate
for Injection, USP, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |